Clinical review: The meaning of acid-base abnormalities in the intensive care unit - effects of fluid administration

被引:84
作者
Morgan, TJ [1 ]
机构
[1] Mater Misericordiae Hosp, Brisbane, Qld, Australia
来源
CRITICAL CARE | 2005年 / 9卷 / 02期
关键词
D O I
10.1186/cc2946
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Stewart's quantitative physical chemical approach enables us to understand the acid-base properties of intravenous fluids. In Stewart's analysis, the three independent acid-base variables are partial CO2 tension, the total concentration of nonvolatile weak acid (A(TOT)), and the strong ion difference (SID). Raising and lowering A(TOT) while holding SID constant cause metabolic acidosis and alkalosis, respectively. Lowering and raising plasma SID while clamping A(TOT) cause metabolic acidosis and alkalosis, respectively. Fluid infusion causes acid-base effects by forcing extracellular SID and A(TOT) toward the SID and A(TOT) of the administered fluid. Thus, fluids with vastly differing pH can have the same acid-base effects. The stimulus is strongest when large volumes are administered, as in correction of hypovolaemia, acute normovolaemic haemodilution, and cardiopulmonary bypass. Zero SID crystalloids such as saline cause a 'dilutional' acidosis by lowering extracellular SID enough to overwhelm the metabolic alkalosis of A(TOT) dilution. A balanced crystalloid must reduce extracellular SID at a rate that precisely counteracts the A(TOT) dilutional alkalosis. Experimentally, the crystalloid SID required is 24 mEq/l. When organic anions such as L-lactate are added to fluids they can be regarded as weak ions that do not contribute to fluid SID, provided they are metabolized on infusion. With colloids the presence of A(TOT) is an additional consideration. Albumin and gelatin preparations contain A(TOT), whereas starch preparations do not. Hextend is a hetastarch preparation balanced with L-lactate. It reduces or eliminates infusion related metabolic acidosis, may improve gastric mucosal blood flow, and increases survival in experimental endotoxaemia. Stored whole blood has a very high effective SID because of the added preservative. Large volume transfusion thus causes metabolic alkalosis after metabolism of contained citrate, a tendency that is reduced but not eliminated with packed red cells. Thus, Stewart's approach not only explains fluid induced acid-base phenomena but also provides a framework for the design of fluids for specific acid-base effects.
引用
收藏
页码:204 / 211
页数:8
相关论文
共 69 条
[1]   Management of life-threatening acid-base disorders -: Second of two parts [J].
Adrogué, HJ ;
Madias, NE .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02) :107-111
[2]  
BELLOMO R, 2003, OHS INTENSIVE CARE M, P453
[3]   Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury - A randomized controlled trial [J].
Cooper, DJ ;
Myles, PS ;
McDermott, FT ;
Murray, LJ ;
Laidlaw, J ;
Cooper, G ;
Tremayne, AB ;
Bernard, SS ;
Ponsford, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (11) :1350-1357
[4]   BICARBONATE DOES NOT IMPROVE HEMODYNAMICS IN CRITICALLY ILL PATIENTS WHO HAVE LACTIC-ACIDOSIS - A PROSPECTIVE, CONTROLLED CLINICAL-STUDY [J].
COOPER, DJ ;
WALLEY, KR ;
WIGGS, BR ;
RUSSELL, JA .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (07) :492-498
[5]   DEVELOPMENT OF METABOLIC ALKALOSIS AFTER MASSIVE TRANSFUSION DURING ORTHOTOPIC LIVER-TRANSPLANTATION [J].
DRISCOLL, DF ;
BISTRIAN, BR ;
JENKINS, RL ;
RANDALL, S ;
DZIK, WH ;
GERSON, B ;
BLACKBURN, GL .
CRITICAL CARE MEDICINE, 1987, 15 (10) :905-908
[6]   Diagnosis of metabolic acid-base disturbances in critically ill patients [J].
Fencl, V ;
Jabor, A ;
Kazda, A ;
Figge, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (06) :2246-2251
[7]   Anion gap and hypoalbuminemia [J].
Figge, J ;
Jabor, A ;
Kazda, A ;
Fencl, V .
CRITICAL CARE MEDICINE, 1998, 26 (11) :1807-1810
[8]  
Finfer S, 2004, NEW ENGL J MED, V350, P2247
[9]   Sodium bicarbonate for the treatment of lactic acidosis [J].
Forsythe, SM ;
Schmidt, GA .
CHEST, 2000, 117 (01) :260-267
[10]   Hextend®, a physiologically balanced plasma expander for large volume use in major surgery:: A randomized phase III clinical trial [J].
Gan, TJ ;
Bennett-Guerrero, E ;
Phillips-Bute, B ;
Wakeling, H ;
Moskowitz, DM ;
Olufolabi, Y ;
Konstadt, SN ;
Bradford, C ;
Glass, PSA ;
Machin, SJ ;
Mythen, MG .
ANESTHESIA AND ANALGESIA, 1999, 88 (05) :992-998